APA (7th ed.) Citation

RA, J., EA, D., JD, C., PF, D., T, C., Z, J., . . . AR, T. (2025). Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome cell models through transcriptomic and proteomic analysis. Oncogene, 44(23), 1833. https://doi.org/10.1038/s41388-025-03325-z

Chicago Style (17th ed.) Citation

RA, Jones, et al. "Characterizing the Tumor Suppressor Activity of FLCN in Birt-Hogg-Dubé Syndrome Cell Models Through Transcriptomic and Proteomic Analysis." Oncogene 44, no. 23 (2025): 1833. https://doi.org/10.1038/s41388-025-03325-z.

MLA (9th ed.) Citation

RA, Jones, et al. "Characterizing the Tumor Suppressor Activity of FLCN in Birt-Hogg-Dubé Syndrome Cell Models Through Transcriptomic and Proteomic Analysis." Oncogene, vol. 44, no. 23, 2025, p. 1833, https://doi.org/10.1038/s41388-025-03325-z.